EMEA-002319-PIP01-17

Key facts

Active substance
Rezafungin acetate
Therapeutic area
Infectious diseases
Decision number
P/0014/2019
PIP number
EMEA-002319-PIP01-17
Pharmaceutical form(s)
  • Powder for solution for infusion
  • Age-appropriate dosage form for parenteral use
Condition(s) / indication(s)
Treatment of invasive candidiasis
Route(s) of administration
Intravenous use
Contact for public enquiries
Cidara Therapeutics, Inc.

E-mail: info@cidara.com
Tel. +1 8587 526170

 

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating